Focused on the discovery and development of novel therapeutics acting exclusively in the gastrointestinal tract and devoid of systemic exposure
- Year invested 2008
- Investment Stage Early
- Sectors
- Investment Status Current
- Associated Team
- Website ardelyx.com
- Company Status IPO/Public (NASDAQ: ARDX)